Verity Pharmaceuticals

NJ - EwingPharmaceutical2 H-1B visas (FY2023)

Website LinkedIn Careers Page

Focus: Specialty genitourinary therapies

Verity Pharmaceuticals is a life sciences company focused on Specialty genitourinary therapies.

Neurology

Profile data last refreshed Yesterday

Open Jobs

Data completeness

3/9 — Basic

Company HealthSolid

Pipeline

Mid-stage

2 Phase 3+

LOE Risk

1 imminent

AVEED

Hiring

0 open

Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.

Products & Portfolio (2)

Key Products by Revenue

AVEED

testosterone undecanoate

LOE Approaching

INTRAMUSCULAR · INJECTABLE

androgens, including testosterone and dihydrotestosterone (DHT) are responsible for the normal growth and development of the male sex organs and for maintenance of secondary sex characteristics. These effects include the growth and maturation of prostate, seminal vesicles, penis, and scrotum; the development of male hair distribution, such as facial, pubic, chest, and axillary hair; laryngeal enlargement; vocal cord thickening; and alterations in body musculature and fat distribution. Male hypogonadism, a clinical syndrome resulting from insufficient secretion of testosterone, has 2 main etiologies. Primary hypogonadism is caused by defects of the gonads, such as Klinefelter's syndrome or Leydig cell aplasia, whereas secondary hypogonadism is the failure of the hypothalamus (or pituitary) to produce sufficient gonadotropins (FSH, LH).

Help build intelligence for Verity Pharmaceuticals

No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.

Share Interview Share Compensation

Data Sources

Drug label: DailyMed / FDA
Clinical trials: ClinicalTrials.gov
Patent data: FDA Orange Book
Spending data: CMS Medicare

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.

Pipeline & Clinical Trials

Focus group

Anorectal Malformations

N/A

Clinical Trials (1)

NCT05749406Parental Attitudes to Neoanus Dilatations Post-reconstruction in Anorectal Malformations

N/A

Bacillus Calmette-Guerin: Strain Russian BCG-I

Bladder Cancer

Phase 3

Clinical Trials (1)

NCT05037279Evaluating Safety and Efficacy of Verity-BCG in BCG-naïve Patients With Intermediate and High-risk Non-muscle Invasive Bladder (NMIBC)

Phase 3

VPM1002

SARS-CoV-2 Infection

Phase 3

Clinical Trials (1)

NCT04439045Efficacy and Safety of VPM1002 in Reducing SARS-CoV-2 (COVID-19) Infection Rate and Severity

Phase 3

Interview Prep Quick Facts

Portfolio: 5 approved products, 3 clinical trials

Top TAs: Oncology, Women's Health, Endocrinology

H-1B (2023): 2 approvals

Portfolio Health

Peak2 (40%)

LOE Approaching3 (60%)

5 total products

Therapeutic Area Focus

3 marketed1 pipeline

3 marketed

2 marketed

2 marketed

2 marketed

Visa Sponsorship

Sponsors Work Visas

H-1B Petitions (FY2023)

Approved

Denied

100%

Rate

Source: USCIS H-1B Employer Data Hub

Verity Pharmaceuticals

Products & Portfolio (2)

Key Products by Revenue

Other Products (1)

Pipeline & Clinical Trials

Open Jobs (0)

Visa Sponsorship